Home

Robert S Radie

CIK 1591113 · Principal Financial Officer · last filed 2026-07-06

Robert S Radie is a Principal Financial Officer who has filed 44 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for RMTI, was dated Jul 6, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $167.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$167.7K

Companies

3

Total Filings

44

Lifetime Open-Market Net

-$1.92M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RMTI Director 23,985 $6.99 $167.7K $0 8 2026-07-06
Paratek Pharmaceuticals, Inc. (PRTK) Delisted Director 20,000 $2.23 $44.6K -$69.4K 12 2023-09-21
Zyla Life Sciences (EGLT) Delisted President and CEO 834,900 — — -$1.85M 21 2018-06-15

Recent Filings

44 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-06 RMTI Grant (A) +9,633 $0 EDGAR
2025-05-21 RMTI Grant (A) +50,000 $0 EDGAR
2024-05-23 RMTI Grant (A) +36,111 $0 EDGAR
2023-09-21 Paratek Pharmaceuticals, Inc. (PRTK) Delisted Disp (D) −73,000 $0 EDGAR
2023-05-25 RMTI Grant (A) +24,715 $0 EDGAR
2023-02-09 Paratek Pharmaceuticals, Inc. (PRTK) Delisted Grant (A) +20,000 $0 EDGAR
2022-06-09 RMTI Grant (A) +25,000 $0 EDGAR
2022-02-18 Paratek Pharmaceuticals, Inc. (PRTK) Delisted Grant (A) +20,000 $0 EDGAR
2021-06-22 RMTI Grant (A) +50,000 $0 EDGAR
2021-02-22 Paratek Pharmaceuticals, Inc. (PRTK) Delisted Grant (A) +9,000 $0 EDGAR
Showing 1–10 of 44
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.